No treatment given: Clinical Trials

94 trials of No treatment given, newest first
ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

80 completed, 7 enrolling by invitation, 3 recruiting, 3 withdrawn. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow No treatment given: new trials by email Literature Review of No treatment given trials Research Report on No treatment given

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Patient Preferences in Treatment of Haemophilia A With and Without Inhibitors: a Discrete Choice Experiment in Germany
No treatment given - Haemophilia A		Enrolling by invitationNovo Nordisk A/S1502026-09-252026-10-06
A Retrospective Real-World Cohort Study
No treatment given - Obesity, Type 2 Diabetes (T2D)		Active not recruitingNovo Nordisk A/S1000002026-08-202026-09-30
Treatment Patterns, Biochemical Profiles and Clinical Outcomes in Adults With X-Linked Hypophosphatemia
No treatment given - X-linked Hypophosphatemia (XLH)		WithdrawnNovo Nordisk A/S2026-07-072026-08-28
Prevalence and Overlap of Cardiovascular, Kidney, and Metabolic Diseases in Korea: A Population-based Study
No treatment given - Diabetes Mellitus, Type 2, Obesity		Enrolling by invitationNovo Nordisk A/S8000002026-06-082026-06-29
A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Participants
No treatment given - Diabetes Mellitus, Type 2		RecruitingNovo Nordisk A/S4002026-03-132026-07-28
Database Linkage Study to Evaluate the Risk of Medullary Thyroid Carcinoma
No treatment given - Medullary Thyroid Carcinoma		Enrolling by invitationNovo Nordisk A/S936000002025-12-312026-08-04
Current Status of Cardiovascular Diseases in Chinese Overweight/ Obesity Population: An Epidemiological Study (COPE）
No treatment given - Obesity, Overweight		CompletedNovo Nordisk A/S5519312025-12-082026-01-22
A Multi-country, Cross-sectional Quantitative Study Exploring Awareness, Understanding, and Perceptions of the Relation Between Cardiorenal Metabolic Conditions and MASLD/MASH Among Healthcare Providers, People With MASLD/MASH, and At-risk Population
No treatment given - Metabolic Dysfunction-associated Steatohepatitis (MASH)		CompletedNovo Nordisk A/S13302025-10-022026-03-12
Characteristics and Treatment Experiences of Individuals Using Injectable Semaglutide for Weight Management, a Cross-sectional Time-series Analysis, Multi-country Study.
No treatment given - Obesity		Enrolling by invitationNovo Nordisk A/S25462025-09-262025-11-25
Focus on Levels of Awareness and Perceptions Regarding hsCRP in Identifying Systemic Inflammation in ASCVD, CKD and Heart Failure Management
No treatment given - Atherosclerotic Cardiovascular Disease, Heart Failure		CompletedNovo Nordisk A/S6082025-09-182026-02-11
A Master Protocol for Semaglutide Effects on Cardiovascular and Obesity-related Outcomes in People With Overweight or Obesity in the Real World
No treatment given - Overweight, Obesity		CompletedNovo Nordisk A/S2853272025-08-292026-01-23
A Study Collecting Remote Data in People With an Overweight Condition or Obesity on a Weight Management Program
No treatment given - Overweight, Obesity		CompletedNovo Nordisk A/S1462025-04-142026-05-04
CAPTIVATE India - A Study to Assess the Prevalence of Cardiovascular Disease (CVD) in Individuals With Type 2 Diabetes Mellitus (T2DM) in India
No treatment given - Type 2 Diabetes Mellitus		CompletedNovo Nordisk A/S15002025-04-092025-08-13
Prevalence of Weight Related Complications Across Diverse Weight Classifications - A Large Study in India, Pakistan, Philippines and Vietnam
No treatment given - Obesity, Obesity-related Complications		CompletedNovo Nordisk A/S11702025-03-182026-04-08
Defeat Rare Disease in Asia and Pacific (APAC) DRDA - Haemophilia
No treatment given - Haemophilia		Enrolling by invitationNovo Nordisk A/S2442025-01-312025-10-24
A Real-world Assessment in Implementation of the MASH Patient Care Pathway in Chinese Population Using the Meinian Health Check-up Database
No treatment given - Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) & Steatohepatitis (MASH)		CompletedNovo Nordisk A/S12339702025-01-212025-06-22
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity in the Real World
No treatment given - Overweight, Obesity		CompletedNovo Nordisk A/S454562024-12-062025-05-21
Levels of Inflammation in Middle East People With Cardiovascular Disease With/Without Kidney Disease
No treatment given - Systemic Inflammation (hsCRP)		CompletedNovo Nordisk A/S7562024-11-222025-10-21
A Disease Area Study on the Awareness and Perceptions of Systemic Inflammation and hsCRP as a biomARKer in Patients With ASCVD and CKD in China Among Cardiologists and Nephrologists
No treatment given - Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD)		CompletedNovo Nordisk A/S15002024-09-092025-12-05
Insulin Initiation and Adherence Behaviours: a Cross Sectional Survey of Indian HCPs & Patients With Type 2 Diabetes
No treatment given - Type 2 Diabetes		CompletedNovo Nordisk A/S7522024-07-052024-08-28

Showing 20 of 94. Sign in to see all of them.

Conditions studied

Diabetes Mellitus, Type 2 (38)  ·  Diabetes Mellitus (29)  ·  Obesity (24)  ·  Diabetes Mellitus, Type 1 (20)  ·  Hemophilia A (10)  ·  Hemophilia B (9)  ·  Overweight (7)  ·  Renal Insufficiency, Chronic (7)  ·  Atherosclerosis (6)  ·  Heart Failure (3)  ·  Carcinoma, Medullary (2)  ·  Dwarfism, Pituitary (2)  ·  Nutrition Disorders (2)  ·  Cardiovascular Diseases (1)  ·  Diabetes Complications (1)

Sponsors

Novo Nordisk A/S (92)  ·  Chiesi Farmaceutici S.p.A. (1)  ·  Robert G. Grossman, MD (1)

Countries

United States (27)  ·  India (20)  ·  Germany (15)  ·  United Kingdom (13)  ·  Canada (12)  ·  Japan (10)  ·  Australia (9)  ·  Denmark (9)  ·  France (9)  ·  Malaysia (9)  ·  South Korea (9)  ·  Italy (8)  ·  Saudi Arabia (8)  ·  Spain (8)  ·  China (7)

Top investigators

Annette Stemhagen, DrPH, FISPE (1)  ·  Bizhan Aarabi, MD (1)  ·  Christopher I Shaffrey, MD (1)  ·  Christopher J Neal, MD (1)  ·  Chun-Po Yen, MD (1)  ·  Emily Sieg, MD (1)  ·  Fabian Hoti (1)

Results publications

PMID 34315481, PMID 35012646, PMID 17062774, PMID 22313123, PMID 23150949, PMID 23150950, PMID 23273515, PMID 23331167, PMID 23701236, PMID 23710839, PMID 23710971, PMID 23711019, PMID 23902228, PMID 24944934, PMID 25079662, PMID 25907127, PMID 26619194, PMID 26721814, PMID 27161418, PMID 28360512, PMID 28528246, PMID 28602812, PMID 28750429, PMID 28888148, PMID 28951336, PMID 29062399, PMID 29086529, PMID 29106039, PMID 29347915, PMID 29355651, PMID 29433560, PMID 29433573, PMID 29524189, PMID 29581204, PMID 29686173, PMID 29709335, PMID 29729048, PMID 30090731, PMID 30383482, PMID 30456887, PMID 30879256, PMID 31032548, PMID 31155994, PMID 31294535, PMID 31584770, PMID 31595670, PMID 31666040, PMID 32158432, PMID 32385580, PMID 33087177

NIH funding

2015 (1)